Modeling mutation-specific arrhythmogenic phenotypes in isogenic human iPSC-derived cardiac tissues

• Published in: Scientific reports Vol. 14; no. 1; p. 2586
• Main Authors: Maurissen, Thomas L, Kawatou, Masahide, López-Dávila, Víctor, Minatoya, Kenji, Yamashita, Jun K, Woltjen, Knut
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 31.01.2024; Nature Publishing Group UK; Nature Portfolio
• Subjects: Action Potentials - genetics; Arrhythmias, Cardiac - genetics; Cardiomyocytes; Cell differentiation; Coronary artery disease; ERG1 Potassium Channel - genetics; Genetic disorders; Genome editing; Heart diseases; Humans; Induced Pluripotent Stem Cells - physiology; Long QT Syndrome - genetics; Mesenchyme; Missense mutation; Mutation; Myocytes, Cardiac - physiology; Phenotype; Phenotypes; Pluripotency; Stem cells
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-024-52871-1

Disease modeling using human induced pluripotent stem cells (hiPSCs) from patients with genetic disease is a powerful approach for dissecting pathophysiology and drug discovery. Nevertheless, isogenic controls are required to precisely compare phenotypic outcomes from presumed causative mutations rather than differences in genetic backgrounds. Moreover, 2D cellular models often fail to exhibit authentic disease phenotypes resulting in poor validation in vitro. Here we show that a combination of precision gene editing and bioengineered 3D tissue models can establish advanced isogenic hiPSC-derived cardiac disease models, overcoming these drawbacks. To model inherited cardiac arrhythmias we selected representative N588D and N588K missense mutations affecting the same codon in the hERG potassium channel gene KCNH2, which are reported to cause long (LQTS) and short (SQTS) QT syndromes, respectively. We generated compound heterozygous variants in normal hiPSCs, and differentiated cardiomyocytes (CMs) and mesenchymal cells (MCs) to form 3D cardiac tissue sheets (CTSs). In hiPSC-derived CM monolayers and 3D CTSs, electrophysiological analysis with multielectrode arrays showed prolonged and shortened repolarization, respectively, compared to the isogenic controls. When pharmacologically inhibiting the hERG channels, mutant 3D CTSs were differentially susceptible to arrhythmic events than the isogenic controls. Thus, this strategy offers advanced disease models that can reproduce clinically relevant phenotypes and provide solid validation of gene mutations in vitro.